Psoriasis is a non-contagious, chronic autoimmune disease that causes the body to attack itself and create raised, inflamed, scaly, red skin lesions known as plaques, which may crack and bleed.
Psoriasis is more than skin lesions; it is painful and can impact many aspects of a person's life from professional and social activities to personal relationships. People with psoriasis may also suffer from poor self-image and social isolation.
Tumor necrosis factor alpha (TNF-a) is a protein that when produced in excess, plays a central role in the inflammatory responses of many immune-mediated diseases. HUMIRA® works by blocking this protein.
Already approved in 67 countries, HUMIRA® is the only fully human monoclonal antibody approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) in the United States and Europe.
Find more details from the full report.
Comment Preview